James Samuel Shannon
CIK 1485417 · last filed 2026-05-22
James Samuel Shannon is a corporate insider who has filed 40 SEC Form 4 insider transactions across 4 companies since 2010. The most recent filing, for MNKD, was dated May 22, 2026. Across all open-market trades the lifetime net is −$1.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $216.5K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$216.5K
4
40
-$1.23M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MNKD | Director | 36,458 | $3.66 | $133.4K | $0 | 18 | 2026-05-22 |
| XLO | Director | 10,000 | $8.31 | $83.1K | $92.0K | 4 | 2026-03-30 |
| Horizon Therapeutics Public Ltd Co (HZNP) Delisted | Director | 0 | $116.30 | $0 | -$1.32M | 15 | 2023-10-06 |
| ENDOCYTE INC (ECYT) Delisted | Director | — | — | — | $0 | 3 | 2011-05-31 |
Recent Filings
40 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-22 | MNKD | Grant (A) | — | $0 | EDGAR |
| 2026-03-30 | XLO | Buy (P) | +5,000 | $43.9K | EDGAR |
| 2026-03-03 | MNKD | Grant (A) | +12,000 | $39.2K | EDGAR |
| 2025-06-18 | XLO | Buy (P) | +70,000 | $48.1K | EDGAR |
| 2025-06-12 | XLO | Grant (A) | — | $0 | EDGAR |
| 2025-05-16 | MNKD | Grant (A) | — | $0 | EDGAR |
| 2024-06-17 | XLO | Grant (A) | — | $0 | EDGAR |
| 2024-05-17 | MNKD | Grant (A) | — | $0 | EDGAR |
| 2023-10-06 | Horizon Therapeutics Public Ltd Co (HZNP) Delisted | Disp (D) | −56,794 | -$6.62M | EDGAR |
| 2023-10-02 | Horizon Therapeutics Public Ltd Co (HZNP) Delisted | Exer (M) | +11,850 | $144.5K | EDGAR |